These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 22870778

  • 1. [Comparative study of crystallization processes in case of glycine crystallization].
    Aigner Z, Szegedi A, Szabadi V, Ambrus R, Sovány T, Szabóné Révész P.
    Acta Pharm Hung; 2012; 82(2):61-8. PubMed ID: 22870778
    [Abstract] [Full Text] [Related]

  • 2. Reduction of glycine particle size by impinging jet crystallization.
    Tari T, Fekete Z, Szabó-Révész P, Aigner Z.
    Int J Pharm; 2015 Jan 15; 478(1):96-102. PubMed ID: 25448571
    [Abstract] [Full Text] [Related]

  • 3. Crystallization of glycine with ultrasound.
    Louhi-Kultanen M, Karjalainen M, Rantanen J, Huhtanen M, Kallas J.
    Int J Pharm; 2006 Aug 31; 320(1-2):23-9. PubMed ID: 16759826
    [Abstract] [Full Text] [Related]

  • 4. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
    Murnane D, Marriott C, Martin GP.
    Eur J Pharm Biopharm; 2008 May 31; 69(1):72-82. PubMed ID: 18082385
    [Abstract] [Full Text] [Related]

  • 5. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
    Murnane D, Marriott C, Martin GP.
    Eur J Pharm Biopharm; 2008 May 31; 69(1):94-105. PubMed ID: 17981448
    [Abstract] [Full Text] [Related]

  • 6. Crystallization of progesterone for pulmonary drug delivery.
    Ragab D, Rohani S, Samaha MW, El-Khawas FM, El-Maradny HA.
    J Pharm Sci; 2010 Mar 31; 99(3):1123-37. PubMed ID: 19691108
    [Abstract] [Full Text] [Related]

  • 7. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E, Cho W, Cha KH, Park J, Kim MS, Kim JS, Park HJ, Hwang SJ.
    Int J Pharm; 2010 Aug 30; 396(1-2):91-8. PubMed ID: 20558265
    [Abstract] [Full Text] [Related]

  • 8. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
    Padrela L, Rodrigues MA, Velaga SP, Matos HA, de Azevedo EG.
    Eur J Pharm Sci; 2009 Aug 12; 38(1):9-17. PubMed ID: 19477273
    [Abstract] [Full Text] [Related]

  • 9. Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process.
    Paulino AS, Rauber G, Campos CE, Maurício MH, de Avillez RR, Capobianco G, Cardoso SG, Cuffini SL.
    Eur J Pharm Sci; 2013 May 13; 49(2):294-301. PubMed ID: 23557843
    [Abstract] [Full Text] [Related]

  • 10. Polymorphic control of inhalation microparticles prepared by crystallization.
    Murnane D, Marriott C, Martin GP.
    Int J Pharm; 2008 Sep 01; 361(1-2):141-9. PubMed ID: 18582548
    [Abstract] [Full Text] [Related]

  • 11. Applications of process analytical technology to crystallization processes.
    Yu LX, Lionberger RA, Raw AS, D'Costa R, Wu H, Hussain AS.
    Adv Drug Deliv Rev; 2004 Feb 23; 56(3):349-69. PubMed ID: 14962586
    [Abstract] [Full Text] [Related]

  • 12. [Particle size reduction using acoustic cavitation].
    Bartos C, Ambrus R, Szabóné RP.
    Acta Pharm Hung; 2014 Feb 23; 84(4):131-5. PubMed ID: 25872275
    [Abstract] [Full Text] [Related]

  • 13. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
    Deng Z, Xu S, Li S.
    Int J Pharm; 2008 Mar 03; 351(1-2):236-43. PubMed ID: 18093763
    [Abstract] [Full Text] [Related]

  • 14. Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery.
    Bakhbakhi Y, Charpentier PA, Rohani S.
    Int J Pharm; 2006 Feb 17; 309(1-2):71-80. PubMed ID: 16412594
    [Abstract] [Full Text] [Related]

  • 15. Spherical crystallization of drugs.
    Kovačič B, Vrečer F, Planinšek O.
    Acta Pharm; 2012 Mar 17; 62(1):1-14. PubMed ID: 22472445
    [Abstract] [Full Text] [Related]

  • 16. Development of spherical iron(II) sulfate heptahydrate-containing solid particles with sustained drug release.
    Szabó-Révész P, Farkas B, Gregor T, Nagy K, Pallagi E.
    Eur J Pharm Biopharm; 2007 May 17; 66(2):193-9. PubMed ID: 17125982
    [Abstract] [Full Text] [Related]

  • 17. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C, MacRitchie HB, Zeng XM, Martin GP.
    Int J Pharm; 2006 Dec 01; 326(1-2):39-49. PubMed ID: 16942848
    [Abstract] [Full Text] [Related]

  • 18. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
    Zhang F, Aaltonen J, Tian F, Saville DJ, Rades T.
    Eur J Pharm Biopharm; 2009 Jan 01; 71(1):64-70. PubMed ID: 18703139
    [Abstract] [Full Text] [Related]

  • 19. Analysis of niflumic acid prepared by rapid microwave-assisted evaporation.
    Radacsi N, Stefanidis GD, Szabó-Révész P, Ambrus R.
    J Pharm Biomed Anal; 2014 Sep 01; 98():16-21. PubMed ID: 24873734
    [Abstract] [Full Text] [Related]

  • 20. Spherical crystallization of benzoic acid.
    Katta J, Rasmuson AC.
    Int J Pharm; 2008 Feb 04; 348(1-2):61-9. PubMed ID: 17765414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.